FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014077960> ?p ?o ?g. }

• W2014077960 endingPage "985" @default.
• W2014077960 startingPage "981" @default.
• W2014077960 abstract "Abstract Treatment options for metastatic castration-resistant prostate cancer (CRPC) have evolved with the established benefit of the novel androgen receptor (AR)-targeted agents abiraterone and enzalutamide in the prechemotherapy setting. However, concerns regarding cross-resistance between the taxanes docetaxel and cabazitaxel and these AR-targeted agents have arisen, and the optimal drug treatment sequence is unknown. We investigated the in vivo efficacy of docetaxel and cabazitaxel in enzalutamide-resistant CRPC, and mechanisms of cross-resistance between these agents. Castrated mice harboring enzalutamide-resistant tumors and enzalutamide-naive tumors were treated with docetaxel and cabazitaxel. Tumor growth kinetics, AR nuclear localization, AR-regulated gene expression, Ki67 expression, and serum levels of prostate-specific antigen, docetaxel, and cabazitaxel were analyzed. Docetaxel inhibited tumor growth, AR nuclear localization, and AR-regulated gene expression in enzalutamide-naive tumors, but did not in enzalutamide-resistant tumors, demonstrating in vivo cross-resistance. By contrast, cabazitaxel remained highly effective in enzalutamide-resistant tumors and demonstrated superior antitumor activity compared to docetaxel, independent of the AR pathway. These findings demonstrate that the AR pathway is able to confer in vivo cross-resistance between enzalutamide and docetaxel, but not cabazitaxel, in CRPC. Patient summary We found reduced efficacy of docetaxel, but not cabazitaxel, in enzalutamide-resistant prostate cancer." @default.
• W2014077960 created "2016-06-24" @default.
• W2014077960 creator A5007844500 @default.
• W2014077960 creator A5010797456 @default.
• W2014077960 creator A5013175033 @default.
• W2014077960 creator A5013888438 @default.
• W2014077960 creator A5041610986 @default.
• W2014077960 creator A5046203732 @default.
• W2014077960 creator A5046404259 @default.
• W2014077960 creator A5074174053 @default.
• W2014077960 date "2015-06-01" @default.
• W2014077960 modified "2023-09-30" @default.
• W2014077960 title "Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer" @default.
• W2014077960 cites W1969202480 @default.
• W2014077960 cites W2004361934 @default.
• W2014077960 cites W2054334976 @default.
• W2014077960 cites W2108679313 @default.
• W2014077960 cites W2114282601 @default.
• W2014077960 cites W2116607127 @default.
• W2014077960 cites W2137467802 @default.
• W2014077960 cites W2166918329 @default.
• W2014077960 cites W2170668585 @default.
• W2014077960 cites W3147725646 @default.
• W2014077960 doi "https://doi.org/10.1016/j.eururo.2014.11.033" @default.
• W2014077960 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25484141" @default.
• W2014077960 hasPublicationYear "2015" @default.
• W2014077960 type Work @default.
• W2014077960 sameAs 2014077960 @default.
• W2014077960 citedByCount "113" @default.
• W2014077960 countsByYear W20140779602014 @default.
• W2014077960 countsByYear W20140779602015 @default.
• W2014077960 countsByYear W20140779602016 @default.
• W2014077960 countsByYear W20140779602017 @default.
• W2014077960 countsByYear W20140779602018 @default.
• W2014077960 countsByYear W20140779602019 @default.
• W2014077960 countsByYear W20140779602020 @default.
• W2014077960 countsByYear W20140779602021 @default.
• W2014077960 countsByYear W20140779602022 @default.
• W2014077960 countsByYear W20140779602023 @default.
• W2014077960 crossrefType "journal-article" @default.
• W2014077960 hasAuthorship W2014077960A5007844500 @default.
• W2014077960 hasAuthorship W2014077960A5010797456 @default.
• W2014077960 hasAuthorship W2014077960A5013175033 @default.
• W2014077960 hasAuthorship W2014077960A5013888438 @default.
• W2014077960 hasAuthorship W2014077960A5041610986 @default.
• W2014077960 hasAuthorship W2014077960A5046203732 @default.
• W2014077960 hasAuthorship W2014077960A5046404259 @default.
• W2014077960 hasAuthorship W2014077960A5074174053 @default.
• W2014077960 hasConcept C121608353 @default.
• W2014077960 hasConcept C126322002 @default.
• W2014077960 hasConcept C126894567 @default.
• W2014077960 hasConcept C143998085 @default.
• W2014077960 hasConcept C150903083 @default.
• W2014077960 hasConcept C207001950 @default.
• W2014077960 hasConcept C2776235491 @default.
• W2014077960 hasConcept C2776551883 @default.
• W2014077960 hasConcept C2777511904 @default.
• W2014077960 hasConcept C2777899217 @default.
• W2014077960 hasConcept C2777911890 @default.
• W2014077960 hasConcept C2778971682 @default.
• W2014077960 hasConcept C2780192828 @default.
• W2014077960 hasConcept C2781190966 @default.
• W2014077960 hasConcept C502942594 @default.
• W2014077960 hasConcept C530470458 @default.
• W2014077960 hasConcept C61367390 @default.
• W2014077960 hasConcept C71315377 @default.
• W2014077960 hasConcept C71924100 @default.
• W2014077960 hasConcept C86803240 @default.
• W2014077960 hasConceptScore W2014077960C121608353 @default.
• W2014077960 hasConceptScore W2014077960C126322002 @default.
• W2014077960 hasConceptScore W2014077960C126894567 @default.
• W2014077960 hasConceptScore W2014077960C143998085 @default.
• W2014077960 hasConceptScore W2014077960C150903083 @default.
• W2014077960 hasConceptScore W2014077960C207001950 @default.
• W2014077960 hasConceptScore W2014077960C2776235491 @default.
• W2014077960 hasConceptScore W2014077960C2776551883 @default.
• W2014077960 hasConceptScore W2014077960C2777511904 @default.
• W2014077960 hasConceptScore W2014077960C2777899217 @default.
• W2014077960 hasConceptScore W2014077960C2777911890 @default.
• W2014077960 hasConceptScore W2014077960C2778971682 @default.
• W2014077960 hasConceptScore W2014077960C2780192828 @default.
• W2014077960 hasConceptScore W2014077960C2781190966 @default.
• W2014077960 hasConceptScore W2014077960C502942594 @default.
• W2014077960 hasConceptScore W2014077960C530470458 @default.
• W2014077960 hasConceptScore W2014077960C61367390 @default.
• W2014077960 hasConceptScore W2014077960C71315377 @default.
• W2014077960 hasConceptScore W2014077960C71924100 @default.
• W2014077960 hasConceptScore W2014077960C86803240 @default.
• W2014077960 hasIssue "6" @default.
• W2014077960 hasLocation W20140779601 @default.
• W2014077960 hasOpenAccess W2014077960 @default.
• W2014077960 hasPrimaryLocation W20140779601 @default.
• W2014077960 hasRelatedWork W1983664569 @default.
• W2014077960 hasRelatedWork W2018704721 @default.
• W2014077960 hasRelatedWork W2074990730 @default.
• W2014077960 hasRelatedWork W2263206436 @default.
• W2014077960 hasRelatedWork W2305036325 @default.
• W2014077960 hasRelatedWork W2394866715 @default.

• next